Protection of Amyloid β Protein (25-35)-induced Neuronal Cell Damage by Methanol Extract of New Stem of Phyllostachys nigra Munro var. henonis Stapf in Cultured Rat Cortical Neuron
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Caulis Bambusae in Taenia is widely used in Korea and China due to its various pharmacological activity. The present study aims to investigate the effect of the methanol extract of Caulis Bambusae in Taenia (CB) from Phyllostachys nigraMunro var. henonis Stapf (Gramineae) on amyloid β protein (25-35) (Aβ (25-35)), a synthetic 25-35 amyloid peptide, -induced neurotoxicity using cultured rat cortical neurons. CB, over a concentration range of 10-50.㎍/㎕.ㅤ, inhibited the Aβ (25-35) (10 μM)-induced neuronal cell death, as assessed by a 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) assay and the number of apoptotic nuclei, evidenced by Hoechst 33342 staining. CB (50.㎍/㎕.ㅤ) inhibited glutamate release into medium induced by 10.μM Aβ (25-35), which was measured by HPLC. Pretreatment of CB (50.ㅤ.㎍/㎕.ㅤ) inhibited 10.μM Aβ (25- .ㅤ 35)-induced elevation of cytosolic calcium concentration ([Ca2+]C), which was measured by a fluorescent dye, fluo-4 AM, and generation of reactive oxygen species. These results suggest that CB prevents Aβ (25-35)-induced neuronal ell damage in vitro.
Abstract
Caulis Bambusae in Taenia is widely used in Korea and China due to its various pharmacological activity. The present study aims to investigate the effect of the methanol extract of Caulis Bambusae in Taenia (CB) from Phyllostachys nigraMunro var. henonis Stapf (Gramineae) on amyloid β protein (25-35) (Aβ (25-35)), a synthetic 25-35 amyloid peptide, -induced neurotoxicity using cultured rat cortical neurons. CB, over a concentration range of 10-50.㎍/㎕.ㅤ, inhibited the Aβ (25-35) (10 μM)-induced neuronal cell death, as assessed by a 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) assay and the number of apoptotic nuclei, evidenced by Hoechst 33342 staining. CB (50.㎍/㎕.ㅤ) inhibited glutamate release into medium induced by 10.μM Aβ (25-35), which was measured by HPLC. Pretreatment of CB (50.ㅤ.㎍/㎕.ㅤ) inhibited 10.μM Aβ (25- .ㅤ 35)-induced elevation of cytosolic calcium concentration ([Ca2+]C), which was measured by a fluorescent dye, fluo-4 AM, and generation of reactive oxygen species. These results suggest that CB prevents Aβ (25-35)-induced neuronal ell damage in vitro.
참고문헌 (31)
- "β-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices", 41, pp.561~566 (1995)
- "Blockade of 5-HT3 receptor with MDL72222 and Y25130 reduces amyloid β protein -induced neurotoxicity in cultured rat cortical cells" (2005)
- "Induction of cytochrome c-mediated apoptosis by amyloid β 25-35 requires functional mitochondria", 931, pp.117~125 (2002)
- "Neuropathology of synthetic β-amyloid peptide analogs in vivo", pp.44~50 (1994)
- "a discussion of in vitro findings", pp.587~13 590 (1992)
- "β-Amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation", 76, pp.389~395 (2000)
- "Activation of the L voltage-sensitive calcium channel by mitogen-activated protein kinase following exposure of neuronal cells to beta-amyloid", 274, pp.30322~30327 (1999)
- "Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection", pp.305~19 315 (1987)
- "Determination of intracellular Ca2+ concentration can be useful tool to predict neuronal damage and neuroprotective properties of drugs", 732, pp.87~94 (1996)
- "Wan Mi-zhai's Zhu Ru Tang (Caulis Bambusae", pp.1~5 (2002), Blue Poppy Press
- "Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury", pp.1~12 (1994)
- "Neurodegeneration mediated by glutamate and peptide: a comparison and possible interaction", 691, pp.169~179 (1995)
- "Neuroprotective approaches in experimental models of β-amyloid neurotoxicity:.relevance to Alzheimer's disease", 23, pp.963~1008 (1999)
- "Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes", 4, pp.97~100 (1998)
- "Disturbances of calcium homeostasis in ischemic stroke", 11, pp.373~386 (1999)
- "Age-related CNS disorder and early death in transgenic FVB", N mice overexpressing Alzheimer amyloid precursor proteins, 1995, pp.15, 1203~1208
- "Multiple pathways of apoptosis in PC12 cells CrmA inhibits apoptosis induced by beta-amyloid", 274, pp.2107~2112 (1999)
- "Transdermal pain palliative agents containing Chinese medicinal herbs", 5, pp.7~11 (2003)
- "β-Amyloid protein increases the vulnerability of cultured neurons to excitotoxic damage", pp.315~320 (1990)
- "Stimulation of 5-HT1A receptor with 8-OH-DPAT inhibits hydrogen peroxide-induced neurotoxicity in cultured rat cortical cells", 51(3), pp.261~268 (2005)
- "Phosphatidic acid-induced elevation of intracellular Ca2+ is mediated RhoA and H2O2 in rat-2 fibroblasts", 273, pp.12710~12715 (1998)
- "NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neutoxicity", 22, pp.3070~3080 (2002)
- "The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease", 62, pp.633~648 (2000)
- "β-Amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex Reversal by NMDA", 45, pp.405~411 (1998)
- "Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis", 37, pp.227~236 (2000)
- "Neuroprotective approaches in experimental models of β-amyloid neurotoxicity relevance to Alzheimer's disease", 23, pp.963~1008 (1999)
- "neurotoxic properties of aggregated amyloid β protein", pp.240~244 (1994)
- "Amyloid β protein potentiates Ca2+ influx through L-type voltage sensitive Ca2+ channels", 68, pp.265~271 (1997)
- "β-Amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons", 92, pp.177~184 (1999)
- "Market and development status of pain-relief drugs", 21, pp.230~236 (2002)
- "Market and development status of pain-relief drugs", 21, pp.230~236 (2002)
